VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CXCEMEX, S.A.B. de C.V.
$10.72$1.6B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCXFinancials

CEMEX, S.A.B. de C.V. (CX) Income Statement

30Y historyFree accessUpdated daily

Revenue growth has recovered to 8.1% in 2026Q3 from -8.3% in 2025Q1 with gross margin expanding to 35.5% from a 31.1% trough, though TTM growth of only 0.4% suggests much of this represents ground recovery rather than genuine expansion.

Income StatementBalance SheetCash FlowRatios

CX Income Statement

Annual statement

CX Income Statement

CEMEX, S.A.B. de C.V. (CX) annual income statement — 30-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue17.35B16.13B16.06B16.4B14.71B14.38B12.67B12.96B13.53B650.76M580.24M731.11M985.26M1.14B1.13B998.44M1.16B1.16B1.39B1.99B1.68B1.56B762.13M651.62M582.97M618.16M501.44M432.76M385.19M425.41M319.95M
Revenue Growth %10.55%0.43%-2.08%11.55%2.27%13.5%-2.24%-4.23%1979.25%12.15%-20.64%-25.79%-13.39%0.76%13.07%-14.24%0.59%-16.56%-30.3%18.15%7.69%105.23%16.96%11.78%-5.69%23.28%15.87%12.35%-9.46%32.96%-
Cost of Goods Sold11.42B10.82B10.65B10.87B10.22B9.74B8.59B8.71B8.85B421.14M372.01M481.79M663.97M780.92M794.75M716.05M837.87M817.25M946.33M1.33B1.08B946.53M428.88M375.65M325.69M347.7M236.58M202.25M187.64M260.69M194.01M
COGS % of Revenue-67.08%66.33%66.25%69.5%67.76%67.77%67.24%65.4%64.71%64.11%65.9%67.39%68.65%70.4%71.72%71.97%70.61%68.23%66.63%63.83%60.52%56.27%57.65%55.87%56.25%47.18%46.73%48.71%61.28%60.64%
Gross Profit5.93B5.31B5.41B5.54B4.49B4.64B4.08B4.25B4.68B229.62M208.23M249.33M321.29M356.65M334.22M282.39M326.35M340.13M440.7M664.04M609.16M617.58M333.25M275.96M257.27M270.45M264.86M230.51M197.55M164.72M125.94M
Gross Margin %34.16%32.92%33.67%33.75%30.5%32.24%32.23%32.76%34.6%35.29%35.89%34.1%32.61%31.35%29.6%28.28%28.03%29.39%31.77%33.37%36.17%39.48%43.73%42.35%44.13%43.75%52.82%53.27%51.29%38.72%39.36%
Gross Profit Growth %--1.79%-2.31%23.43%-3.26%13.54%-3.82%-9.33%1938.98%10.27%-16.48%-22.4%-9.91%6.71%18.35%-13.47%-4.05%-22.82%-33.63%9.01%-1.36%85.32%20.76%7.26%-4.87%2.11%14.9%16.69%19.93%30.79%-
Operating Expenses3.64B3.52B3.58B3.59B3.12B3B4.55B3.28B3.27B152.6M129.28M169.83M238.46M270.5M268.26M247.53M297.51M247.44M280.35M391.25M337.35M363.74M160.05M143.64M140.52M122.83M117.32M101.75M92.42M64.2M49.67M
OpEx % of Revenue-21.83%22.32%21.88%21.24%20.86%35.95%25.31%24.2%23.45%22.28%23.23%24.2%23.78%23.76%24.79%25.55%21.38%20.21%19.66%20.03%23.26%21%22.04%24.1%19.87%23.4%23.51%23.99%15.09%15.53%
Selling, General & Admin1.7B1.57B1.47B1.45B1.19B1.05B1.11B1.14B2.98B142.28M125.39M159.73M213.6M241.44M236.8M220.02M255.99M247.44M280.35M391.25M337.35M363.65M162.82M145.16M140.52M122.83M73.7M62.88M57.34M64.2M49.67M
SG&A % of Revenue-9.73%9.13%8.81%8.1%7.3%8.75%8.8%22.02%21.86%21.61%21.85%21.68%21.22%20.98%22.04%21.99%21.38%20.21%19.66%20.03%23.25%21.36%22.28%24.1%19.87%14.7%14.53%14.89%15.09%15.53%
Research & Development0000000000000000000000000000000
R&D % of Revenue-------------------------------
Other Operating Expenses4M1.95B2.12B2.14B1.93B1.95B3.44B2.14B296M10.32M3.88M10.11M24.86M29.06M31.46M27.52M41.52M000093.53K-2.77M-1.52M0-8943.62M38.86M35.07M00
Operating Income2.29B1.79B1.82B1.95B1.36B1.64B-471M965M1.41B77.03M78.96M79.49M82.83M86.15M65.96M34.86M28.84M92.68M160.35M272.8M271.82M253.84M173.2M132.32M116.75M147.62M147.54M128.76M105.13M100.52M76.27M
Operating Margin %13.2%11.09%11.35%11.86%9.25%11.38%-3.72%7.45%10.4%11.84%13.61%10.87%8.41%7.57%5.84%3.49%2.48%8.01%11.56%13.71%16.14%16.23%22.73%20.31%20.03%23.88%29.42%29.75%27.29%23.63%23.84%
Operating Income Growth %--1.87%-6.32%42.98%-16.86%447.56%-148.81%-31.41%1726.6%-2.44%-0.67%-4.02%-3.86%30.62%89.22%20.85%-68.88%-42.2%-41.22%0.36%7.08%46.56%30.89%13.33%-20.91%0.05%14.58%22.47%4.59%31.8%-
EBITDA3.63B3.08B3.06B3.12B2.43B2.76B634M2B2.39B922.68M850.21M128.36M150.35M170.81M166.25M128.7M154.07M211.54M281.42M421.27M381.83M365.24M253.36M207.31M184.93M218.4M191.16M167.62M140.21M100.52M76.27M
EBITDA Margin %20.93%19.09%19.03%19.01%16.54%19.17%5%15.46%17.66%141.78%146.53%17.56%15.26%15.02%14.73%12.89%13.23%18.28%20.29%21.17%22.67%23.35%33.24%31.81%31.72%35.33%38.12%38.73%36.4%23.63%23.84%
EBITDA Growth %23.34%0.75%-1.99%28.2%-11.75%334.86%-68.36%-16.12%158.92%8.52%562.37%-14.63%-11.98%2.74%29.18%-16.47%-27.17%-24.83%-33.2%10.33%4.54%44.16%22.21%12.1%-15.32%14.25%14.04%19.56%39.48%31.8%-
D&A (Non-Cash Add-back)1.34B1.29B1.23B1.17B1.07B1.12B1.1B1.04B982M845.65M771.26M48.87M67.52M84.66M100.3M93.85M125.23M118.86M121.08M148.47M110.02M111.39M80.16M74.99M68.18M70.78M43.62M38.86M35.07M00
EBIT1.67B1.28B1.58B1.9B1.1B1.56B-510M988M1.44B87.95M90.95M77.51M96.75M97.79M75.72M21.46M22.22M51.91M-77.28M272.8M271.82M253.75M173.29M132.32M116.75M147.62M147.54M128.76M105.13M100.52M76.27M
Net Interest Income-430.26M-527.6M-577M-506.21M-374M-636M-757M-687.61M-704M-1B-1.07B-1.23B-1.49B-1.53B-1.47B-1.23B-1.22B-1B-704.13M-7.95B-4.84B-5.59B-3.89B-4.08B-2.99B-3.38B-4.34B0-4.8B0-4.92B
Interest Income29.51M15.95M18M37.31M27M22M20M20.93M18M17.88M20.13M20.28M21.99M33.21M48.3M35.12M35.6M28.34M42.09M862.27M496.57M0261.05M187.33M463.08M370.95M162.88M000689.2M
Interest Expense459.77M543.55M595M543.52M401M658M777M708.53M722M1.02B1.04B1.25B1.46B1.56B1.43B1.67B1.32B993.61M743.17M8.81B5.33B5.59B4.15B4.27B3.45B3.75B4.5B04.8B05.6B
Other Income/Expense-1.07B-1B-832M-620M-791M-683M-839M-727M-690M-43.75M-37.99M-67.94M-91.94M-107.34M-96.29M-102.14M-103.31M-119.84M-300.31M-5.88M-7.2M-7.39M-32.83M-65.8M-65.51M-27.56M-44.3M-35.46M-29.31M2.38M34.09M
Pretax Income1.22B789M991M1.33B570M954M-1.31B238M717M33.28M40.97M11.55M-9.12M-21.19M-30.34M-67.29M-74.46M-27.16M-139.97M266.92M264.62M246.45M140.37M66.52M51.24M120.06M103.24M93.31M75.82M102.9M110.36M
Pretax Margin %7.06%4.89%6.17%8.08%3.88%6.63%-10.34%1.84%5.3%5.11%7.06%1.58%-0.93%-1.86%-2.69%-6.74%-6.4%-2.35%-10.09%13.41%15.71%15.76%18.42%10.21%8.79%19.42%20.59%21.56%19.68%24.19%34.49%
Income Tax516.87M385M67M1.21B168M137M36M157M224M805.52K7.27M7.89M19.32M36.82M34.62M63.81M13.59M-61.82M-141.35M40.31M44.86M34.23M17.18M8.11M4.89M14.89M14.09M6.13M4.12M7.45M9.44M
Effective Tax Rate %42.2%48.8%6.76%90.87%29.47%14.36%-2.75%65.97%31.24%2.42%17.74%68.36%-211.89%-173.77%-114.13%-94.83%-18.25%227.67%100.99%15.1%16.95%13.89%12.24%12.2%9.53%12.41%13.65%6.57%5.44%7.24%8.55%
Net Income626.07M960M939M182M858M753M-1.47B143M528M39.87M32.63M4M-33.42M-64.74M-68.76M-131.2M-88.36M8.24M14M219.54M219.48M215.59M122.21M57.15M46.35M105.16M89.15M87.18M71.7M85.43M92.89M
Net Margin %3.61%5.95%5.85%1.11%5.83%5.24%-11.58%1.1%3.9%6.13%5.62%0.55%-3.39%-5.69%-6.09%-13.14%-7.59%0.71%1.01%11.03%13.03%13.78%16.03%8.77%7.95%17.01%17.78%20.14%18.61%20.08%29.03%
Net Income Growth %-54.11%2.24%415.93%-78.79%13.94%151.33%-1125.87%-72.92%1224.19%22.19%715.03%111.98%48.37%5.84%47.6%-48.49%-1171.74%-41.12%-93.62%0.03%1.81%76.41%113.82%23.3%-55.92%17.96%2.26%21.59%-16.08%-8.03%-
Net Income (Continuing)707.86M404M924M121M402M817M-1.35B81M493M32.47M33.7M3.65M-28.43M-58.01M-64.96M-131.09M-88.06M34.67M1.39M219.54M219.48M215.59M122.21M57.15M46.35M105.16M89.15M87.18M71.7M85.43M92.89M
Discontinued Operations786K566M36M78M483M-39M-100M98M77M11.18M1.66M3.43M00000-25.02M0000000000000
Minority Interest305.76M307.68M301M352M408M444M877M1.5B1.57B1.58B964.78M735.79M691.94M1.14B1.12B1.19B1.58B3.35B3.36B3.76B1.91B527.65M388.69M532.58M1.21B1.98B2.4B1.26B1.25B00
EPS (Diluted)4.296.600.610.120.580.50-0.980.090.330.520.460.05-0.28-0.50-0.71-1.10-1.100.090.162.202.402.301.400.701.201.702.402.702.202.502.40
EPS Growth %356.52%981.97%408.33%-79.31%16%151.02%-1176.92%-72.42%-36.54%13.04%858.33%117.14%44%29.58%35.45%0%-1350%-45%-92.73%-8.33%4.35%64.29%100%-41.67%-29.41%-29.17%-11.11%22.73%-12%4.17%-
EPS (Basic)-6.600.610.120.590.51-1.000.100.350.520.460.05-0.33-0.61-0.71-1.10-1.100.090.162.202.402.301.500.711.201.702.402.702.202.502.70
Diluted Shares Outstanding145.8M144.89M1.47B1.47B1.48B1.5B1.5B1.58B1.6B1.61B1.65B1.63B1.63B1.65B1.31B1.27B1.26B1.18B1.05B1.1B1.06B949.87M915.96M882.67M442.11M694.08M410.71M364.55M372.36M384.91M438.3M
Basic Shares Outstanding144.1M144.89M1.47B1.47B1.48B1.47B1.47B1.51B1.54B1.52B1.49B1.46B1.4B1.37B1.31B1.27B1.26B1.18B1.05B1.1B1.06B946.92M911.23M862.78M441.25M694.08M408.94M363.1M372.36M379.15M382.82M
Dividend Payout Ratio-13.32%9.58%65.93%5.94%3.18%-125.17%----------3639.07%276.94%241.93%231.92%317.23%629.87%704.86%290.05%257.6%228.85%231.38%-147.24%

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Earnings quality obscured by anomalies

Top-Line Recovery Gains Momentum in 2026

Revenue growth swung from -8.3% contraction in 2025Q1 to 8.1% expansion in 2026Q3, marking a meaningful cyclical recovery, though management's two consecutive quarters of withheld forward guidance, per CX's earnings disclosures, suggests uncertainty around durability of this rebound.

The revenue path from 2024Q2 through 2025Q1 shows a deteriorating trend with sequential growth rates of -2.8%, -7.1%, and -8.3%, consistent with weakening construction demand across key end markets during a rising-rate environment. Starting in 2025Q3, growth reaccelerated sharply to 11.2-11.8% through 2026Q2 before moderating to 8.1%, suggesting either genuine volume recovery in the US Sunbelt and Mexico or favorable MXN/USD and EUR/USD translation effects. The inability to disaggregate organic from FX-driven growth without segment-level detail is a key analytical gap that limits conviction in the durability of this inflection, particularly given the absence of forward guidance from the company.

Gross Margin Recovery Signals Pricing Discipline

Gross margin expanded 440 basis points from a trough of 31.1% in 2025Q1 to 35.5% in 2026Q3, reflecting a combination of pricing power and moderating energy input costs, as reported in CX's quarterly financial statements.

The gross margin trajectory demonstrates a clear recovery pattern, climbing from 31.1% through successive quarterly expansions to 35.5%, which matches the peak last observed in 2024Q2. This suggests that the 'price-over-cost' strategy referenced in CX's operational framework is gaining traction, with pricing more than offsetting residual inflationary pressures in petcoke, diesel, and freight. However, the operating margin tells a far more volatile story, swinging from 6.8% in 2025Q1 to 38.9% in 2026Q3—a 3,210-basis-point range that is fundamentally inconsistent with a stable operational profile and points to significant below-gross-profit distortion that warrants careful normalization before drawing structural margin conclusions.

Reported Earnings Distorted by Unusual Line Items

CX reported negative SG&A of -$872.2M in 2025Q4 and -$1.1B in 2024Q4, alongside a net loss of -$355.7M in 2025Q4 and an anomalous EPS of $5.69, suggesting significant non-recurring accounting items materially distort the underlying earnings trajectory as disclosed in financial filings.

The presence of negative SG&A in two quarters out of ten is a striking anomaly that likely reflects reversals of previously recognized restructuring provisions, impairment write-backs, or expense reclassifications, though the specific accounting treatment requires reconciliation with CX's footnotes. In 2026Q3, SG&A is reported at zero while operating income of $1.8B exceeds gross profit of $1.6B—a mathematically inconsistent relationship that may reflect a data anomaly or unusual non-operating income recognition. Excluding these outlier periods, normalized operating margins cluster in the 11-15% range, and normalized net margins in the 5-10% band, suggesting that CX's sustainable profitability is materially more modest than headline figures imply.

Overhead Efficiency Supports Operating Leverage

SG&A held steady at $775-890M across standard quarters while revenue expanded 8-11% in 2026, indicating improving overhead absorption, and zero reported R&D expenditure across all periods suggests CX relies on operational integration rather than formal innovation spending for cost competitiveness.

The stability of SG&A within a narrow band during the 2026 revenue recovery phase implies meaningful operating leverage, as corporate overhead has not scaled proportionally with top-line expansion—potentially reflecting digital platform efficiencies from the Cemex Go initiative. COGS has tracked revenue at approximately 64-69% of sales, confirming that energy and raw materials remain the dominant cost exposures, which makes CX's alternative fuel substitution rate the single most important variable cost management lever. The complete absence of reported R&D spend is notable for a company pursuing decarbonization targets; this may indicate that innovation-related expenditures are capitalized within COGS or classified under capital projects, which would require reconciliation with CX's cash flow statement to assess the true investment intensity.

Flat TTM Growth Undermines Rebound Narrative

Despite sequential quarterly growth rates of 8-11% in 2026, trailing twelve-month revenue growth of just 0.4% YoY against stable 32.9% gross margins, as referenced in CX's recent earnings communications, suggests the company has merely recovered lost ground rather than achieved genuine expansion.

The apparently strong 2026 quarterly growth rates may largely reflect base effects from depressed prior-year comparables rather than organic demand strength, as the TTM figure of 0.4% reveals that cumulative top-line expansion over a full cycle is effectively flat. Furthermore, the normalized net margin range of 5-10% (excluding anomalous quarters) significantly trails US-listed peers such as MLM at 17.4% and VMC at 13.6%, indicating that the valuation discount applied to CX reflects genuine structural margin inferiority attributable to emerging market cost structures and currency translation headwinds rather than pure multiple mispricing. Investors should also monitor whether the 2026Q3 operating margin of 38.9%—driven by a reported SG&A of zero—represents a data artifact rather than genuine performance, as normalization of this figure could materially alter forward earnings expectations.

CX — Frequently Asked Questions

Quick answers to the most common questions about buying CX stock.

What was CEMEX, S.A.B. de C.V.'s (CX) revenue in 2025?

For fiscal year 2025, CEMEX, S.A.B. de C.V. (CX) reported total revenue of $16.13B. This represents a 4942.0% increase compared to $320.0M in 1996.

Is CEMEX, S.A.B. de C.V. (CX) profitable?

CEMEX, S.A.B. de C.V. (CX) is profitable, generating $960.0M in net income for the fiscal year ending 2025 with a net profit margin of 6.0%.

What is CEMEX, S.A.B. de C.V.'s operating profit margin?

CEMEX, S.A.B. de C.V. (CX) reported an operating income of $1.79B, resulting in an operating profit margin of 11.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is CEMEX, S.A.B. de C.V.'s gross profit and gross margin?

CEMEX, S.A.B. de C.V. (CX) generated $5.31B in gross profit for the year, representing a gross profit margin of 32.9%. This demonstrates the company's core pricing power and production efficiency.